David B. Wells - 13 May 2025 Form 4 Insider Report for Trade Desk, Inc. (TTD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 May 2025, 17:05:25 UTC
Prior SEC filing
17 Dec 2024
Next SEC filing
16 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelli Faerber, Attorney-In-Fact for David B. Wells

Key filing fact

David B. Wells filed Form 4 for Trade Desk, Inc. (TTD) on 15 May 2025.

Key facts

  • This page summarizes David B. Wells's Form 4 filing for Trade Desk, Inc. (TTD).
  • 25 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 15 May 2025, 17:05.

Change

  • Previous filing in this sequence was filed on 17 Dec 2024.
  • Current net transaction value: -$618,547.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001507645 Primary reporting owner

WELLS DAVID B

Relationship
Director
Address
C/O THE TRADE DESK, INC., 42 NORTH CHESTNUT STREET, VENTURA
Signature
/s/ Kelli Faerber, Attorney-In-Fact for David B. Wells
Signature date
15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$408,621
Shares
+6,990
Change %
+10%
Price
$58.46
Shares after
73,975
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$81,257
Shares
+1,390
Change %
+1.9%
Price
$58.46
Shares after
75,365
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$39,167
Shares
+670
Change %
+0.89%
Price
$58.46
Shares after
76,035
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$12,861
Shares
+220
Change %
+0.29%
Price
$58.46
Shares after
76,255
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$334,679
Shares
+6,826
Change %
+9%
Price
$49.03
Shares after
83,081
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$66,926
Shares
+1,365
Change %
+1.6%
Price
$49.03
Shares after
84,446
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$32,115
Shares
+655
Change %
+0.78%
Price
$49.03
Shares after
85,101
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$10,689
Shares
+218
Change %
+0.26%
Price
$49.03
Shares after
85,319
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$482,505
Shares
+7,282
Change %
+8.5%
Price
$66.26
Shares after
92,601
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$91,041
Shares
+1,374
Change %
+1.5%
Price
$66.26
Shares after
93,975
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$91,041
Shares
+1,374
Change %
+1.5%
Price
$66.26
Shares after
95,349
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Options Exercise

Transaction value
$18,155
Shares
+274
Change %
+0.29%
Price
$66.26
Shares after
95,623
Date
13 May 2025
Ownership
Direct
TTD transaction

Class A Common Stock

Sale

Transaction value
$2,287,603
Shares
-28,638
Change %
-30%
Price
$79.88
Shares after
66,985
Date
13 May 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-6,990
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
6,990
Exercise price
$58.46
Footnotes
F3, F4
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,390
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,390
Exercise price
$58.46
Footnotes
F4, F5
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-670
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
670
Exercise price
$58.46
Footnotes
F6, F7
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-220
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
220
Exercise price
$58.46
Footnotes
F8, F9
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-6,826
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
6,826
Exercise price
$49.03
Footnotes
F10
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,365
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,365
Exercise price
$49.03
Footnotes
F10
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-655
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
655
Exercise price
$49.03
Footnotes
F11
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-218
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
218
Exercise price
$49.03
Footnotes
F12
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-7,282
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
7,282
Exercise price
$66.26
Footnotes
F13
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,374
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,374
Exercise price
$66.26
Footnotes
F13
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,374
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,374
Exercise price
$66.26
Footnotes
F14
TTD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-274
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
274
Exercise price
$66.26
Footnotes
F15
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 15 footnotes

Footnote F1

These sales represent the aggregate shares from the twelve acquisitions reported above.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F3

This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.

Footnote F4

The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.

Footnote F5

This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.

Footnote F6

This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.

Footnote F7

The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.

Footnote F8

This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.

Footnote F9

The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.

Footnote F10

The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.

Footnote F11

The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.

Footnote F12

The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.

Footnote F13

The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.

Footnote F14

The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.

Footnote F15

The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .